Balyasny Asset Management L.P. - Sep 30, 2025 SCHEDULE 13G/A Report for Lexeo Therapeutics, Inc. Common Stock, par value $0.0001 per share (LXEO)

Filing Manager
BALYASNY ASSET MANAGEMENT L.P.
Reporting Manager
Balyasny Asset Management L.P.
Security
Lexeo Therapeutics, Inc. Common Stock, par value $0.0001 per share
Symbol
LXEO
Shares outstanding
54M shares
Disclosed Ownership
5.39M shares
Ownership
9.99%
Form type
SCHEDULE 13G/A
Date filed
11/14/2025, 06:04 AM
Date of event
Sep 30, 2025
Previous filing
Aug 14, 2025
SEC
View on sec.gov

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Balyasny Asset Management L.P. 9.99% 5.39M 5.39M 0 /s/ Scott Schroeder Scott Schroeder / Authorized Signatory
BAM GP LLC 9.99% 5.39M 5.39M 0 /s/ Scott Schroeder Scott Schroeder / Authorized Signatory
Balyasny Asset Management Holdings LP 9.99% 5.39M 5.39M 0 /s/ Scott Schroeder Scott Schroeder / Authorized Signatory
Dames GP LLC 9.99% 5.39M 5.39M 0 /s/ Scott Schroeder Scott Schroeder / Authorized Signatory
Dmitry Balyasny 9.99% 5.39M 5.39M 0 /s/ Dmitry Balyasny Dmitry Balyasny / Self